G-CONNECT Academy
G-CONNECT is a premier collaborative ecosystem designed
Informed decision making in the era of expanded NIPT
Dr. Tae Sok Kun (University Malaya Medical Center, Malaysia) addressed the expanding scope of NIPT and the growing need to manage increasing interpretive complexity. With monogenic disorders accounting for an estimated 15–25% of birth defects, and approximately 1–2% of couples being at risk for certain inherited conditions, Dr. Tae emphasized the critical role of structured genetic counseling
An innovative approach to non-invasive prenatal screening in Asia
Dr. Tang Hung Sang (Medical Director, Gene Solutions) described the shift from conventional aneuploidy screening toward a broader, integrated framework. While chromosomal abnormalities account for only part of the genetic contribution to congenital conditions, a meaningful proportion is associated with monogenic disorders, including both dominant and recessive conditions
Redefining Prenatal Screening in Asia: Leveraging NGS and AI for Comprehensive Genetic Screening
Dr. Tang Hung Sang (Medical Genetics Institute, Vietnam) emphasized that the future lies in unified prenatal platforms capable of delivering comprehensive insights—aneuploidies, carrier status, and single gene disorders within a single workflow supported by advanced computational algorithms
Title
Content
DD/MM/YYYY
Expert Opinions
G-CONNECT is a premier collaborative ecosystem designed
Informed decision making in the era of expanded NIPT
Dr. Tae Sok Kun (University Malaya Medical Center, Malaysia) addressed the expanding scope of NIPT and the growing need to manage increasing interpretive complexity. With monogenic disorders accounting for an estimated 15–25% of birth defects, and approximately 1–2% of couples being at risk for certain inherited conditions, Dr. Tae emphasized the critical role of structured genetic counseling
An innovative approach to non-invasive prenatal screening in Asia
Dr. Tang Hung Sang (Medical Director, Gene Solutions) described the shift from conventional aneuploidy screening toward a broader, integrated framework. While chromosomal abnormalities account for only part of the genetic contribution to congenital conditions, a meaningful proportion is associated with monogenic disorders, including both dominant and recessive conditions
Redefining Prenatal Screening in Asia: Leveraging NGS and AI for Comprehensive Genetic Screening
Dr. Tang Hung Sang (Medical Genetics Institute, Vietnam) emphasized that the future lies in unified prenatal platforms capable of delivering comprehensive insights—aneuploidies, carrier status, and single gene disorders within a single workflow supported by advanced computational algorithms
